Sensus Healthcare Secures New $15M Revolving Credit Facility to Address Liquidity Concerns
Summary
Sensus Healthcare has secured a new $15 million revolving credit facility with City National Bank of Florida, replacing its previously terminated credit line and providing crucial working capital.
Key Events
-
New $15 Million Revolving Credit Facility
Sensus Healthcare, Inc. entered into a Loan Agreement with City National Bank of Florida for a revolving credit facility providing maximum borrowings of $15,000,000.
-
Replaces Terminated Credit Line
This new facility replaces the company's previous revolving credit facility with Fifth Third Bank, N.A., which had been terminated.
-
Secured by Company Assets and Cash Collateral
The loan is secured by a first priority security interest in all of the company's assets and $2,230,000 in cash collateral.
-
Restrictive Covenants and Maturity
The facility has a maturity date of June 5, 2027, and includes financial covenants such as a minimum debt service coverage ratio of 1.50, along with restrictions on asset sales, incurring other debt, or removing key officers without bank consent.
Analysis
Sensus Healthcare, which recently reported a significant revenue decline and increased net loss for Q1 2026, was facing heightened liquidity concerns due to the termination of its previous $15 million credit facility. This new $15 million revolving credit facility, secured with City National Bank of Florida, directly addresses that critical funding gap. While the loan comes with restrictive covenants, including a minimum debt service coverage ratio and limitations on asset sales and executive changes, it provides essential working capital and extends the company's financial runway until June 2027. This is a crucial development for the company's operational continuity, especially as it trades near its 52-week low.
At the time of this filing, SRTS was trading at $2.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $44.4M. The 52-week trading range was $2.66 to $5.92. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.